Form 8-K

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): July 20, 2004

 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

0-24260    11-3131700
(Commission File Number)    (I.R.S. Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

 

(a)    Financial Statements of Business Acquired.

 

Not applicable.

 

(b)    Pro Forma Financial Information.

 

Not applicable.

 

(c)    Exhibit
No.		         Page
     99.1 (i)    Press Release dated July 20, 2004 announcing that the Company will release second quarter operating results on August 3, 2004 and host a conference call at 10:00 a.m. ET that same day    A-1

 

(i) Filed herewith.

 

ITEM 9. REGULATION FD DISCLOSURE

 

On July 20, 2004, Amedisys, Inc., “the Company”, issued a press release attached hereto as Exhibit 99.1 to announce that it will release second quarter operating results on August 3, 2004 and host a conference call at 10:00 a.m. ET that same day.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.

By:   /s/ William F. Borne
   

William F. Borne

Chief Executive Officer

 

DATE: July 21, 2004